PANC-PALS Consortium
@pancpals.bsky.social
www.pancpals.com
The PANC-PALS consortium is committed to providing a platform where pancreatologists can collaborate, share their expertise, and advance patient care.
The PANC-PALS consortium is committed to providing a platform where pancreatologists can collaborate, share their expertise, and advance patient care.
Throwback to #PancreasClub
Honored to present PANC-PALS Collaborator-led consortium and global registry 💪🏻💪🏻
Thank you for everyone’s hard work to get IRBs and contracts signed 📈🧑💻
@ammaraj.bsky.social
Honored to present PANC-PALS Collaborator-led consortium and global registry 💪🏻💪🏻
Thank you for everyone’s hard work to get IRBs and contracts signed 📈🧑💻
@ammaraj.bsky.social
May 19, 2025 at 1:29 PM
Throwback to #PancreasClub
Honored to present PANC-PALS Collaborator-led consortium and global registry 💪🏻💪🏻
Thank you for everyone’s hard work to get IRBs and contracts signed 📈🧑💻
@ammaraj.bsky.social
Honored to present PANC-PALS Collaborator-led consortium and global registry 💪🏻💪🏻
Thank you for everyone’s hard work to get IRBs and contracts signed 📈🧑💻
@ammaraj.bsky.social
What a pleasure to host University of Padova PANC-PALS local PI, @gio-marchegiani.bsky.social, at our HQ this week! 💜
Great discussions followed by a drink by the East River 😎
#PANCPALS
@ammaraj.bsky.social
Great discussions followed by a drink by the East River 😎
#PANCPALS
@ammaraj.bsky.social
May 9, 2025 at 4:23 PM
What a pleasure to host University of Padova PANC-PALS local PI, @gio-marchegiani.bsky.social, at our HQ this week! 💜
Great discussions followed by a drink by the East River 😎
#PANCPALS
@ammaraj.bsky.social
Great discussions followed by a drink by the East River 😎
#PANCPALS
@ammaraj.bsky.social
May 5, 2025 at 4:06 PM
Drop by our #PANCPALS booth at #PancreasClub this weekend, and get your lanyard! 🙌🏻 💜
@ammaraj.bsky.social
@ammaraj.bsky.social
May 3, 2025 at 4:45 PM
Drop by our #PANCPALS booth at #PancreasClub this weekend, and get your lanyard! 🙌🏻 💜
@ammaraj.bsky.social
@ammaraj.bsky.social
PANC-PALS / NYU Langone Health at the #PanCANPurpleStride NYC this past Saturday! 💜☔️
@pancan.bsky.social
@ammaraj.bsky.social
@pancan.bsky.social
@ammaraj.bsky.social
April 28, 2025 at 6:28 PM
PANC-PALS / NYU Langone Health at the #PanCANPurpleStride NYC this past Saturday! 💜☔️
@pancan.bsky.social
@ammaraj.bsky.social
@pancan.bsky.social
@ammaraj.bsky.social
Reposted by PANC-PALS Consortium
Neoadjuvant chemo 🤜🤛 surgery for Resectable PDAC 🇯🇵 RCT
💉 Gemcitabine + S1 median OS 37 months vs. 26
💡 Is neoadjuvant chemo extending survival over upfront surgery?!
🤔 What are your thoughts?! 💭
journals.lww.com/annalsofsurg...
#HPBSky #Surgsky
💉 Gemcitabine + S1 median OS 37 months vs. 26
💡 Is neoadjuvant chemo extending survival over upfront surgery?!
🤔 What are your thoughts?! 💭
journals.lww.com/annalsofsurg...
#HPBSky #Surgsky
April 16, 2025 at 4:54 PM
Neoadjuvant chemo 🤜🤛 surgery for Resectable PDAC 🇯🇵 RCT
💉 Gemcitabine + S1 median OS 37 months vs. 26
💡 Is neoadjuvant chemo extending survival over upfront surgery?!
🤔 What are your thoughts?! 💭
journals.lww.com/annalsofsurg...
#HPBSky #Surgsky
💉 Gemcitabine + S1 median OS 37 months vs. 26
💡 Is neoadjuvant chemo extending survival over upfront surgery?!
🤔 What are your thoughts?! 💭
journals.lww.com/annalsofsurg...
#HPBSky #Surgsky
🚨New publication! 🚨
A new method for evaluating CA19-9 during neoadjuvant therapy, and its role in predicting overall and disease-free survival in BR-PC. A way towards personalised prognostication! 💜💪🏻🙏🏼
doi.org/10.1097/SLA....
A new method for evaluating CA19-9 during neoadjuvant therapy, and its role in predicting overall and disease-free survival in BR-PC. A way towards personalised prognostication! 💜💪🏻🙏🏼
doi.org/10.1097/SLA....
April 16, 2025 at 3:22 PM
🚨New publication! 🚨
A new method for evaluating CA19-9 during neoadjuvant therapy, and its role in predicting overall and disease-free survival in BR-PC. A way towards personalised prognostication! 💜💪🏻🙏🏼
doi.org/10.1097/SLA....
A new method for evaluating CA19-9 during neoadjuvant therapy, and its role in predicting overall and disease-free survival in BR-PC. A way towards personalised prognostication! 💜💪🏻🙏🏼
doi.org/10.1097/SLA....
Staying hydrated everywhere with our #PANCPALS waterbottle 🌊💪🏻
Progressing with contracts, and looking forward to our Azure platform… soon to be ready 👩🏼💻🧑🏽💻
Stay tuned for updates! 💜🤓
@ammaraj.bsky.social
Progressing with contracts, and looking forward to our Azure platform… soon to be ready 👩🏼💻🧑🏽💻
Stay tuned for updates! 💜🤓
@ammaraj.bsky.social
April 11, 2025 at 4:08 PM
Staying hydrated everywhere with our #PANCPALS waterbottle 🌊💪🏻
Progressing with contracts, and looking forward to our Azure platform… soon to be ready 👩🏼💻🧑🏽💻
Stay tuned for updates! 💜🤓
@ammaraj.bsky.social
Progressing with contracts, and looking forward to our Azure platform… soon to be ready 👩🏼💻🧑🏽💻
Stay tuned for updates! 💜🤓
@ammaraj.bsky.social
We are honored to see the #PANCPALS consortium expanding the last few weeks! Already over 80 committed sites globally, and still growing 💪👀
Join us now! Find the joining questionnaire on pancpals.com/joining-ques...
@ammaraj.bsky.social @marcbesselink.bsky.social
Join us now! Find the joining questionnaire on pancpals.com/joining-ques...
@ammaraj.bsky.social @marcbesselink.bsky.social
April 4, 2025 at 8:37 PM
We are honored to see the #PANCPALS consortium expanding the last few weeks! Already over 80 committed sites globally, and still growing 💪👀
Join us now! Find the joining questionnaire on pancpals.com/joining-ques...
@ammaraj.bsky.social @marcbesselink.bsky.social
Join us now! Find the joining questionnaire on pancpals.com/joining-ques...
@ammaraj.bsky.social @marcbesselink.bsky.social
Reposted by PANC-PALS Consortium
👁️ Bordeline observable IPMNs 👁️ our new editorial in @bmj.com GUT
⚖️ Reappraisal of the actual benefit of extended surveillance between cancer risk🫸 🫷discontinuation
🧬 "Less invasive" biomarkers are expected to exclude from FU harmless cyst since first observation
🟠 gut.bmj.com/content/earl...
⚖️ Reappraisal of the actual benefit of extended surveillance between cancer risk🫸 🫷discontinuation
🧬 "Less invasive" biomarkers are expected to exclude from FU harmless cyst since first observation
🟠 gut.bmj.com/content/earl...
March 28, 2025 at 3:54 PM
👁️ Bordeline observable IPMNs 👁️ our new editorial in @bmj.com GUT
⚖️ Reappraisal of the actual benefit of extended surveillance between cancer risk🫸 🫷discontinuation
🧬 "Less invasive" biomarkers are expected to exclude from FU harmless cyst since first observation
🟠 gut.bmj.com/content/earl...
⚖️ Reappraisal of the actual benefit of extended surveillance between cancer risk🫸 🫷discontinuation
🧬 "Less invasive" biomarkers are expected to exclude from FU harmless cyst since first observation
🟠 gut.bmj.com/content/earl...
Very honored that PANC-PALS founder and consortium coordinator @ammaraj.bsky.social was able to introduce the consortium at the #AHPBA this morning #LeveragingLargeDatabases.
Followed by an excellent expert panel discussion. 💪🏻 🩺
Thanks everyone!
#AHPBA2025 #PANCPALS 💜
Followed by an excellent expert panel discussion. 💪🏻 🩺
Thanks everyone!
#AHPBA2025 #PANCPALS 💜
March 24, 2025 at 2:25 AM
Very honored that PANC-PALS founder and consortium coordinator @ammaraj.bsky.social was able to introduce the consortium at the #AHPBA this morning #LeveragingLargeDatabases.
Followed by an excellent expert panel discussion. 💪🏻 🩺
Thanks everyone!
#AHPBA2025 #PANCPALS 💜
Followed by an excellent expert panel discussion. 💪🏻 🩺
Thanks everyone!
#AHPBA2025 #PANCPALS 💜
March 22, 2025 at 4:02 PM
March 22, 2025 at 2:00 PM
Reposted by PANC-PALS Consortium
Can we personalize 📐 surveillance of IPMN?!
🇮🇹 🇺🇸 🇩🇪 🇰🇷 🇳🇱 🇬🇧 🇸🇬 🇪🇸 analysis of 2k IPMN developing WF/HRS
👴 Age and 🫧 cyst size impact the timing of surveillance
🦘 First prudential control always 6 months… then 🦘🦘 2 years if no WF/HRS
journals.lww.com/annalsofsurg...
#HPBSky #SurgSky
🇮🇹 🇺🇸 🇩🇪 🇰🇷 🇳🇱 🇬🇧 🇸🇬 🇪🇸 analysis of 2k IPMN developing WF/HRS
👴 Age and 🫧 cyst size impact the timing of surveillance
🦘 First prudential control always 6 months… then 🦘🦘 2 years if no WF/HRS
journals.lww.com/annalsofsurg...
#HPBSky #SurgSky
March 21, 2025 at 1:07 PM
Can we personalize 📐 surveillance of IPMN?!
🇮🇹 🇺🇸 🇩🇪 🇰🇷 🇳🇱 🇬🇧 🇸🇬 🇪🇸 analysis of 2k IPMN developing WF/HRS
👴 Age and 🫧 cyst size impact the timing of surveillance
🦘 First prudential control always 6 months… then 🦘🦘 2 years if no WF/HRS
journals.lww.com/annalsofsurg...
#HPBSky #SurgSky
🇮🇹 🇺🇸 🇩🇪 🇰🇷 🇳🇱 🇬🇧 🇸🇬 🇪🇸 analysis of 2k IPMN developing WF/HRS
👴 Age and 🫧 cyst size impact the timing of surveillance
🦘 First prudential control always 6 months… then 🦘🦘 2 years if no WF/HRS
journals.lww.com/annalsofsurg...
#HPBSky #SurgSky
Reposted by PANC-PALS Consortium
Congrats to #AnoukEmmen and @tfstoop.bsky.social for excellent presentations in the #PresidentialSession #AHPBA2025 AHPBA Miami 🇺🇸: #DIPLOMA2 RCT🇪🇺 robot/lap 🤖 vs open Whipple and #PREOPANC4🇳🇱 implementation of surgery for locally advanced #PancreaticCancer for @dpcgofficial.bsky.social and #EMIPS
March 21, 2025 at 2:01 PM
Congrats to #AnoukEmmen and @tfstoop.bsky.social for excellent presentations in the #PresidentialSession #AHPBA2025 AHPBA Miami 🇺🇸: #DIPLOMA2 RCT🇪🇺 robot/lap 🤖 vs open Whipple and #PREOPANC4🇳🇱 implementation of surgery for locally advanced #PancreaticCancer for @dpcgofficial.bsky.social and #EMIPS
March 21, 2025 at 2:53 PM
Reposted by PANC-PALS Consortium
Published in #hpbjournal, 🌎 survey on surgical management of pancreatic neck/body cancer with venous involvement:
📝222 surgeons, 49 countries, 6 continents
📍Heterogeneity in surgical management➡️particularly when ⬆️ venous involvement
⚠️ Need for research 🔍
@eahpba.bsky.social @ihpba.bsky.social
📝222 surgeons, 49 countries, 6 continents
📍Heterogeneity in surgical management➡️particularly when ⬆️ venous involvement
⚠️ Need for research 🔍
@eahpba.bsky.social @ihpba.bsky.social
March 16, 2025 at 7:46 AM
Published in #hpbjournal, 🌎 survey on surgical management of pancreatic neck/body cancer with venous involvement:
📝222 surgeons, 49 countries, 6 continents
📍Heterogeneity in surgical management➡️particularly when ⬆️ venous involvement
⚠️ Need for research 🔍
@eahpba.bsky.social @ihpba.bsky.social
📝222 surgeons, 49 countries, 6 continents
📍Heterogeneity in surgical management➡️particularly when ⬆️ venous involvement
⚠️ Need for research 🔍
@eahpba.bsky.social @ihpba.bsky.social
Reposted by PANC-PALS Consortium
Delayed Gastric Emptying 🤢 is an issue after robotic 🤖 PD
2️⃣1️⃣ % overall DGE rate
📹 assessment of technical skills ⬇️ DGE rates (after 35 procedures)
🤔 How do you perform GJ after a robotic PD ?! How do you prevent DGE?! 🫵
journals.lww.com/annalsofsurg...
@marcbesselink.bsky.social #HPBSky
2️⃣1️⃣ % overall DGE rate
📹 assessment of technical skills ⬇️ DGE rates (after 35 procedures)
🤔 How do you perform GJ after a robotic PD ?! How do you prevent DGE?! 🫵
journals.lww.com/annalsofsurg...
@marcbesselink.bsky.social #HPBSky
March 16, 2025 at 1:09 PM
Delayed Gastric Emptying 🤢 is an issue after robotic 🤖 PD
2️⃣1️⃣ % overall DGE rate
📹 assessment of technical skills ⬇️ DGE rates (after 35 procedures)
🤔 How do you perform GJ after a robotic PD ?! How do you prevent DGE?! 🫵
journals.lww.com/annalsofsurg...
@marcbesselink.bsky.social #HPBSky
2️⃣1️⃣ % overall DGE rate
📹 assessment of technical skills ⬇️ DGE rates (after 35 procedures)
🤔 How do you perform GJ after a robotic PD ?! How do you prevent DGE?! 🫵
journals.lww.com/annalsofsurg...
@marcbesselink.bsky.social #HPBSky
Preperations underway for the #AHPBA Miami 2025 at the PANC-PALS HQ! 🙌🏻📂
Come visit us at our booth! #AHPBA #PANCPALS
@ammaraj.bsky.social
Come visit us at our booth! #AHPBA #PANCPALS
@ammaraj.bsky.social
March 14, 2025 at 4:43 PM
Preperations underway for the #AHPBA Miami 2025 at the PANC-PALS HQ! 🙌🏻📂
Come visit us at our booth! #AHPBA #PANCPALS
@ammaraj.bsky.social
Come visit us at our booth! #AHPBA #PANCPALS
@ammaraj.bsky.social
Reposted by PANC-PALS Consortium
Is there a role for neoadjuvant chemo for 🍇 invasive IPMN ?!
🌎 1k resected only 7% after NAT
👍 BR / LAPC no worse OS after NAT
🧪 CA19.9 indicates “biological” treatment effect
👉https://journals.lww.com/annalsofsurgery/abstract/9900/neoadjuvant_chemotherapy_for_intraductal_papillary.1220.aspx
🌎 1k resected only 7% after NAT
👍 BR / LAPC no worse OS after NAT
🧪 CA19.9 indicates “biological” treatment effect
👉https://journals.lww.com/annalsofsurgery/abstract/9900/neoadjuvant_chemotherapy_for_intraductal_papillary.1220.aspx
March 5, 2025 at 4:34 PM
Is there a role for neoadjuvant chemo for 🍇 invasive IPMN ?!
🌎 1k resected only 7% after NAT
👍 BR / LAPC no worse OS after NAT
🧪 CA19.9 indicates “biological” treatment effect
👉https://journals.lww.com/annalsofsurgery/abstract/9900/neoadjuvant_chemotherapy_for_intraductal_papillary.1220.aspx
🌎 1k resected only 7% after NAT
👍 BR / LAPC no worse OS after NAT
🧪 CA19.9 indicates “biological” treatment effect
👉https://journals.lww.com/annalsofsurgery/abstract/9900/neoadjuvant_chemotherapy_for_intraductal_papillary.1220.aspx
Meet our team! #PANCPALS
Meet Dr. Camila Hidalgo Salinas, founder & a consortium coordinator. Dr. Hidalgo Salinas is a Postdoctoral Research Fellow at #NYULangoneHealth #Surgery
She says that with PANC-PALS "We envision a new era of pancreatic cancer research through global collaboration."
Meet Dr. Camila Hidalgo Salinas, founder & a consortium coordinator. Dr. Hidalgo Salinas is a Postdoctoral Research Fellow at #NYULangoneHealth #Surgery
She says that with PANC-PALS "We envision a new era of pancreatic cancer research through global collaboration."
February 27, 2025 at 7:57 PM
Meet our team! #PANCPALS
Meet Dr. Camila Hidalgo Salinas, founder & a consortium coordinator. Dr. Hidalgo Salinas is a Postdoctoral Research Fellow at #NYULangoneHealth #Surgery
She says that with PANC-PALS "We envision a new era of pancreatic cancer research through global collaboration."
Meet Dr. Camila Hidalgo Salinas, founder & a consortium coordinator. Dr. Hidalgo Salinas is a Postdoctoral Research Fellow at #NYULangoneHealth #Surgery
She says that with PANC-PALS "We envision a new era of pancreatic cancer research through global collaboration."
Reposted by PANC-PALS Consortium
A wonderful nationwide collaboration with help of some of our expert friends in 🇺🇸 🇩🇪 !!
February 21, 2025 at 1:57 PM
A wonderful nationwide collaboration with help of some of our expert friends in 🇺🇸 🇩🇪 !!
Reposted by PANC-PALS Consortium
Failure to Rescue After Resection of Perhilar Cholangiocarcinoma in an International Multicenter Cohort @AnnSurgOncol
link.springer.com/article/10.1...
link.springer.com/article/10.1...
Failure to Rescue After Resection of Perhilar Cholangiocarcinoma in an International Multicenter Cohort - Annals of Surgical Oncology
Background Failure to rescue (FTR) is defined as the inability to prevent death after the development of a complication. FTR is a parameter in evaluating multidisciplinary postoperative complication m...
link.springer.com
February 19, 2025 at 12:30 PM
Failure to Rescue After Resection of Perhilar Cholangiocarcinoma in an International Multicenter Cohort @AnnSurgOncol
link.springer.com/article/10.1...
link.springer.com/article/10.1...
Reposted by PANC-PALS Consortium
Can #Video Grading of Bile Duct Anastomoses During Robotic 🤖 #Pancreatoduodenectomy Predicts Bile Leak (BL)?
✅ Videos from 259 pts robotic HJ: 6.9% B/C BL
✅ OSATS score <21 assoc with BL
✅ The rate of BL was 5.1% for OSATS>21 vs 12.5% for OSATS ≤21
▶️ journals.lww.com/annalsofsurg...
✅ Videos from 259 pts robotic HJ: 6.9% B/C BL
✅ OSATS score <21 assoc with BL
✅ The rate of BL was 5.1% for OSATS>21 vs 12.5% for OSATS ≤21
▶️ journals.lww.com/annalsofsurg...
February 17, 2025 at 9:39 PM
Can #Video Grading of Bile Duct Anastomoses During Robotic 🤖 #Pancreatoduodenectomy Predicts Bile Leak (BL)?
✅ Videos from 259 pts robotic HJ: 6.9% B/C BL
✅ OSATS score <21 assoc with BL
✅ The rate of BL was 5.1% for OSATS>21 vs 12.5% for OSATS ≤21
▶️ journals.lww.com/annalsofsurg...
✅ Videos from 259 pts robotic HJ: 6.9% B/C BL
✅ OSATS score <21 assoc with BL
✅ The rate of BL was 5.1% for OSATS>21 vs 12.5% for OSATS ≤21
▶️ journals.lww.com/annalsofsurg...